Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-Month follow-up

Annals of Surgical Oncology

Volumn 17, Issue 8, 2010, Pages 2126-2131

  Kim, Hee Jeong ^a   Son, Byung Ho ^a   Lim, Woo Sung ^a   Seo, Jin Yong ^a   Koh, Beom Seok ^a   Lee, Jong Won ^a   Gong, Gyung Yup ^a   Ahn, Sei Hyun ^a  

^a University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME; ANALYSIS OF VARIANCE; AXILLA; BREAST NEOPLASMS; DISEASE FREE SURVIVAL; LYMPH NODE; MORTALITY; PATHOLOGY; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; TUMOR INVASION; TUMOR RECURRENCE;

ANALYSIS OF VARIANCE; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE;

EID: 77954956151     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0951-1     Document Type: Article

References (20)

1. Bergkvist L, de Boniface J, Jonsson PE, Ingvar C, Liljegren G, Frisell J. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study. Ann Surg. 2008;247:150-6.
2. Kim HJ, Son BH, Park EW, Lim WS, Seo JY, Jang MA, et al. Axillary recurrence after negative sentinel lymph node biopsy. Breast Cancer Res Treat. 2009;114:301-5.
3. Lyman GH, Giuliano AE, Somerfield MR, Benson AB III, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-20.
4. Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368-73.
5. Schwartz GF, Guiliano AE, Veronesi U. Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. Breast J. 2002;8:124-38.
6. Haid A, Koeberle-Wuehrer R, Offner F, Jasarevic Z, Fritzsche H, Zimmermann G. Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer. Chirurg. 2003;74:657-64.
7. McMasters KM, Tuttle TM, Carlson DJ, Brown CM, Noyes RD, Glaser RL, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560-6.
8. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-41.
9. Rudenstam CM, Zahrieh D, Forbes JF, Crivellari D, Holmberg SB, Rey P, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006;24:337-44.
10. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del Bianco P, et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg. 2008;247:207-13.
11. Kim HJ, Lee JS, Park EH, Choi SL, Lim WS, Chang MA, et al. Sentinel node biopsy in patients with multiple breast cancer. Breast Cancer Res Treat. 2008;109:503-6.
12. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002;347:567-75.
13. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 1985;312:674-81.
14. Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer. 1999;35:1320-5.
15. Veronesi U, Orecchia R, Zurrida S, Galimberti V, Luini A, Veronesi P, et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radio-therapy. Ann Oncol. 2005;16:383-8.
16. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7:983-90.
17. Dontu G, El-Ashry D, Wicha MS. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab. 2004;15:193-7. (Pubitemid 38833988)
18. Knauer M, Konstantiniuk P, Haid A, Wenzl E, Riegler-Keil M, Postlberger S, et al. Multicentric breast cancer: a new indication for sentinel node biopsy-a multi-institutional validation study. J Clin Oncol. 2006;24:3374-80.
19. Goyal A, Newcombe RG, Mansel RE, Chetty U, Ell P, Fallow-field L, et al. Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol. 2004;30:475-9. (Pubitemid 38701866)
20. Tousimis E, Van Zee KJ, Fey JV, Hoque LW, Tan LK, Cody HS III, et al. The accuracy of sentinel lymph node biopsy in multi-centric and multifocal invasive breast cancers. J Am Coll Surg. 2003;197:529-35.